Replies to post #168661 on Cytodyn Inc (CYDY)

[misiu143]

I don't know , when I look at a results in our group " B " in CD 12 , critical patients .

With injection of leronlimab given at day 0 and 7 , since FDA refused to also allow us to use at day 14 and 21 ,

The mortality benefit above SOC drugs is very impressive , and so many more patients will survive this pandemic if we only allowed to use leronlimab....

No other drug can do it in the world..

Mortality benefit above SOC drugs in these very sick in our group"B" patients in CD12..

at 7 days --78%
at 14 days --82%
at 21 days --50%
at 28 days --31%..

How is that a fail result....

All IMO.